Allergic rhinitis
Comprehensive research background on the pathophysiology, diagnosis and management of allergic rhinitis.
Featured Indication · Pollen Allergy
Five Core Mechanistic Pathways
These five pathways cover the full chain from upstream immune imbalance to downstream symptom amplification, which is why pollen allergy is isolated as the featured card on the main page.
Immune Rebalancing
Pollen Allergy
The core problem is not pollen itself, but the body's tendency to classify otherwise tolerable environmental particles as danger signals requiring intense response. The platform first targets the excessively active Th2 bias and reduces the allergic amplification tendency associated with IL-4 / IL-5 / IL-13 signaling.
Tolerance Rebuilding
Pollen Allergy
Simply lowering inflammation is not enough, because the local immune system may still remain in a hyper-alert state. The platform therefore raises Treg-linked tolerance signaling so the nasal mucosa can rebuild a more stable immune brake against environmental antigens.
Threshold Reset
Pollen Allergy
Many flare events occur not because exposure is truly massive, but because nasal-associated lymphoid tissue has already begun interpreting very small stimuli as high-priority threats. The platform treats NALT as a threshold-rebuilding node so that short outdoor exposure or minor pollen fluctuations are less likely to trigger the full sneeze-itch-runny cascade.
Neural Desensitization
Pollen Allergy
Severe symptoms do not arise only from stronger inflammation, but from sensory nerves amplifying the signal. By reducing local neural hypersensitization, the platform aims to lessen itch, repeated sneezing, burning, and irritation so that the 'minor stimulus to major symptom' reflex chain becomes less easily triggered.
Barrier Repair
Pollen Allergy
When the nasal barrier remains chronically fragile, pollen particles more easily penetrate and retrigger local recognition, reinforcing allergy over and over again. Beyond immune correction, the platform also supports epithelial tight-junction expression and mucosal integrity to reduce opportunities for allergen penetration and interrupt the cycle of repeated hypersensitization.
Featured Indication Summary
This page extends the featured card on the main screen and explains the lead indication with greater depth and structure.
Published research
The publications below provide general research background on allergic rhinitis, the nasal epithelial barrier, Th2- and histamine-related signaling, and sensory-nerve involvement in rhinitis responses.
Comprehensive research background on the pathophysiology, diagnosis and management of allergic rhinitis.
Research background on nasal epithelial permeability and occludin/ZO-1 expression in patients with house-dust-mite-induced allergic rhinitis, alongside murine-model observations of mucosal permeability.
Research background on epithelial tight-junction changes driven by histamine and T-helper-cell-related cytokines.
Research background on sensory nerves and neurogenic responses involved in rhinitis symptoms.
Material records
The material page below provides existing COA, safety and public report records.
Continue
Pollen allergy is the featured single-disease entry, while the remaining content has been organized into respiratory, cardiopulmonary-axis, and CNS categories.